In 2026, no single GLP-1 medication is in formal FDA shortage, but most still have soft spots somewhere in the supply chain. This piece is a snapshot of where each drug stands by channel: retail pharmacy, mail-order, direct-to-consumer, and compounded. Use it as a starting map.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
All major GLP-1 and GIP\/GLP-1 agonists are off the FDA Drug Shortage Database in 2026.<\/strong> That includes Wegovy\u00ae and Ozempic\u00ae (both semaglutide, Novo Nordisk), Zepbound\u00ae and Mounjaro\u00ae (both tirzepatide, Eli Lilly), Trulicity\u00ae (dulaglutide, Eli Lilly), Saxenda\u00ae (liraglutide, Novo Nordisk), and Rybelsus\u00ae (oral semaglutide, Novo Nordisk).<\/p>\n Quick Answer: All major GLP-1 drugs are off the FDA shortage list as of 2026<\/p>\n Pharmacy-level supply gaps still exist for specific strengths. The 1.7 mg and 2.4 mg Wegovy pens, the 12.5 mg and 15 mg Zepbound pens, and the 0.5 mg and 1 mg Ozempic pens see the most frequent delays. These are all maintenance doses where prescription volume is concentrated.<\/p>\n Manufacturer capacity is up dramatically. Novo Nordisk added more than $6 billion in semaglutide capacity through 2025. Eli Lilly committed $25 billion across 2024 to 2026. Both companies have publicly forecast that residual supply gaps will narrow through Q4 2026.<\/p>\n Retail pharmacies (chain): Inconsistent for 1.7 mg and 2.4 mg, generally good for 0.25 mg, 0.5 mg, 1.0 mg.<\/strong> CVS and Walgreens see periodic regional gaps.<\/p>\n Retail pharmacies (independent): Often better access to wholesale stock than chains. Worth a call before assuming local supply is empty.<\/p>\n Mail-order (Express Scripts, OptumRx, CVS Caremark): Steady supply for ongoing 90-day refills. First-fill turnaround 5 to 10 business days.<\/p>\n NovoCare Direct: $499 per month cash, available for uninsured or fully-cash-pay patients. Shipping 7 to 12 business days.<\/p>\n Compounded (TrimRx and other licensed 503A pharmacies): Available with documented clinical justification on a patient-specific basis. Generally not covered by insurance.<\/p>\n Retail pharmacies (chain): Good for 2.5 mg, 5 mg.<\/strong> Inconsistent for 10 mg, 12.5 mg, 15 mg KwikPens. Vials more consistently stocked than pens.<\/p>\n Retail pharmacies (independent): Often better access than chains for higher doses. Worth a phone call.<\/p>\n Mail-order: Steady supply for ongoing therapy. Single-dose vials ship more reliably than KwikPens.<\/p>\n LillyDirect Self-Pay: $349 per month for 2.5 mg vials, $499 per month for 5 mg through 15 mg vials. Shipping 5 to 10 business days. Pens not available through Self-Pay.<\/p>\n Compounded: Available with documented clinical justification through state-licensed 503A pharmacies.<\/p>\n Retail pharmacies (chain): Good for 0.25 mg, periodic gaps for 0.5 mg, 1.0 mg, and 2.0 mg.<\/strong> The 2 mg high-dose pen is the most often unavailable.<\/p>\n Retail pharmacies (independent): Often better. Call ahead.<\/p>\n Mail-order: Steady supply.<\/p>\n NovoCare savings card: $25 monthly copay for commercially insured patients with diabetes indication. No off-label assistance.<\/p>\n Cash retail: Roughly $950 to $1,050 per month in 2026 depending on strength and location. GoodRx coupons can reduce this by $100 to $200 at participating pharmacies.<\/p>\n Retail (chain): Good for 2.5 mg, 5 mg.<\/strong> Inconsistent for 10 mg, 12.5 mg, 15 mg. Similar pattern to Zepbound.<\/p>\n Retail (independent): Often better at higher doses.<\/p>\n Mail-order: Steady supply through insurance plans.<\/p>\n Lilly Cares: Patient Assistance Program for uninsured or underinsured patients meeting income thresholds, can provide Mounjaro at no cost.<\/p>\n Cash retail: Roughly $1,000 to $1,100 per month in 2026.<\/p>\n Retail (all channels): Consistently stocked.<\/strong> Trulicity demand has shifted toward newer agents and capacity matches demand.<\/p>\n Available doses: 0.75 mg, 1.5 mg, 3 mg, and 4.5 mg weekly.<\/p>\n Mail-order: Reliable.<\/p>\n Cash retail: Roughly $900 to $1,000 per month.<\/p>\n REWIND trial (Gerstein et al. 2019 Lancet) supports cardiovascular outcomes for dulaglutide in type 2 diabetes patients with multiple risk factors. Mean weight loss in clinical trials is modest, roughly 3 to 6 kg at one year.<\/p>\n Key Takeaway: NovoCare and LillyDirect direct-to-consumer channels often have supply when retail doesn’t<\/p>\n Retail (all channels): Consistently stocked.<\/strong> Demand has shifted away from daily injections toward weekly drugs.<\/p>\n Mail-order: Reliable.<\/p>\n Cash retail: Roughly $1,200 to $1,400 per month.<\/p>\n SCALE Obesity trial (Pi-Sunyer et al. 2015 NEJM) showed approximately 8% mean weight loss at 56 weeks, less than half what STEP 1 reported for semaglutide.<\/p>\n Saxenda is daily injection, which is a meaningful adherence cost. Most patients prefer weekly options when available.<\/p>\n Retail (all channels): Generally well-stocked.<\/strong> Oral semaglutide tablets in 3 mg, 7 mg, and 14 mg daily doses.<\/p>\n Approved for type 2 diabetes only. Off-label use for weight loss happens but is not insurance-covered.<\/p>\n PIONEER trial program supports A1C reduction comparable to injectable semaglutide at smaller magnitudes.<\/p>\n Cash retail: Roughly $950 to $1,050 per month.<\/p>\n Compounded semaglutide and tirzepatide remain available in 2026 through state-licensed 503A pharmacies on a patient-specific basis when there’s documented clinical justification.<\/strong><\/p>\n Acceptable clinical reasons: allergies to inactive ingredients, non-standard dose needs, or combination products.<\/p>\n Pricing typically $200 to $500 per month depending on dose and pharmacy. Generally not insurance-covered.<\/p>\n TrimRx partners with licensed compounding pharmacies that follow current FDA guidance. The free assessment quiz documents the clinical case for compounded therapy when it applies.<\/p>\n Ranked from most reliable to least:<\/p>\n The chain retail pharmacy that most patients default to is the least reliable channel for higher-dose GLP-1 therapy in 2026. Switching to mail-order or direct-to-consumer is the single biggest supply improvement most patients can make.<\/p>\n If you have insurance, set up mail-order with your plan’s pharmacy benefit manager.<\/strong> That’s the most reliable ongoing supply channel.<\/p>\n If you’re cash pay, check NovoCare (Wegovy) or LillyDirect Self-Pay (Zepbound) first. They’re cheaper than retail cash and often have supply when retail doesn’t.<\/p>\n If you need a fill in the next 48 hours, use the manufacturer stock locators and call independent pharmacies first.<\/p>\n If your clinical situation supports it, compounded therapy through a licensed 503A pharmacy is a legitimate path with often cheaper monthly costs.<\/p>\n Bottom line: Trulicity and Saxenda remain reliably stocked but produce smaller mean weight loss than newer agents<\/p>\n Per FDA Drug Shortage Database, no. All major brands are listed as resolved. Pharmacy-level supply gaps persist for specific strengths.<\/p>\n Trulicity, Saxenda, and Rybelsus are the most reliably stocked. Newer high-demand drugs (Wegovy 2.4 mg, Zepbound 12.5-15 mg) have more frequent gaps.<\/p>\n No, switching drugs requires prescriber input and clinical rationale. Don’t substitute on your own.<\/p>\n Yes, for ongoing therapy. They negotiate guaranteed allocations from wholesalers that retail pharmacies don’t get.<\/p>\n NovoCare Direct at $499 per month. For Zepbound, LillyDirect Self-Pay at $349-499 per month.<\/p>\n Manufacturer projections say yes through Q4 2026, barring new indication approvals that expand the eligible population.<\/p>\n Supply conditions change weekly. Check manufacturer stock locators and your insurance plan’s mail-order site for current state.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n","protected":false},"excerpt":{"rendered":" In 2026, no single GLP-1 medication is in formal FDA shortage, but most still have soft spots somewhere in the supply chain.<\/p>\n","protected":false},"author":11,"featured_media":93256,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Pharmacy GLP-1 Tracker: Where Each Drug Is Available","_yoast_wpseo_metadesc":"In 2026, no single GLP-1 medication is in formal FDA shortage, but most still have soft spots somewhere in the supply chain.","_yoast_wpseo_focuskw":"pharmacy glp 1","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[6],"tags":[29,47],"class_list":["post-90457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-glp-1","tag-glp-1","tag-shortage"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=90457"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90457\/revisions"}],"predecessor-version":[{"id":91780,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90457\/revisions\/91780"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/93256"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=90457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=90457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=90457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Wegovy Availability Snapshot<\/h2>\n
Zepbound Availability Snapshot<\/h2>\n
Ozempic Availability Snapshot<\/h2>\n
Mounjaro Availability Snapshot<\/h2>\n
Trulicity Availability Snapshot<\/h2>\n
Saxenda Availability Snapshot<\/h2>\n
Rybelsus Availability Snapshot<\/h2>\n
Compounded GLP-1 Availability Snapshot<\/h2>\n
What Channels Have the Most Reliable Supply in 2026?<\/h2>\n
\n
What Does This All Mean for Picking a Pharmacy?<\/h2>\n
FAQ<\/h2>\n
Is Any GLP-1 Drug Actually in Shortage in 2026?<\/h3>\n
Which Has the Most Consistent Supply Right Now?<\/h3>\n
Should I Switch to Whatever I Can Find?<\/h3>\n
Do Mail-order Pharmacies Really Have Steadier Supply?<\/h3>\n
What’s the Cheapest Cash Path for Wegovy?<\/h3>\n
Will Supply Improve in 2026?<\/h3>\n
How Often Is This Tracker Updated?<\/h3>\n